152 related articles for article (PubMed ID: 29963997)
21. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
[TBL] [Abstract][Full Text] [Related]
22. [Myoepithelial carcinoma of the lacrimal gland].
Moret A; Tabareau-Delalande F; Joly A; de Muret A; Goga D; Laure B
Rev Stomatol Chir Maxillofac Chir Orale; 2014 Jun; 115(3):172-7. PubMed ID: 24456911
[TBL] [Abstract][Full Text] [Related]
23. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
24. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
Asai S; Sumiyoshi S; Yamada Y; Tateya I; Nagao T; Minamiguchi S; Haga H
Pathol Int; 2021 Jun; 71(6):427-434. PubMed ID: 33848386
[TBL] [Abstract][Full Text] [Related]
25. A case of recurrent lacrimal gland tumor treated by orbital exenteration.
Suzuki S
Jpn J Clin Oncol; 2012 Jun; 42(6):560. PubMed ID: 22645242
[No Abstract] [Full Text] [Related]
26. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
[TBL] [Abstract][Full Text] [Related]
27. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
[TBL] [Abstract][Full Text] [Related]
28. [Carcinoma of the lacrimal sac: a clinicopathologic case study].
Pereira D; Meyer A; Slama M; Hugol D; D'Hermies F
J Fr Ophtalmol; 2009 Jun; 32(6):452-6. PubMed ID: 19515455
[TBL] [Abstract][Full Text] [Related]
29. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
[TBL] [Abstract][Full Text] [Related]
30. [Malignant tumors of the lacrimal gland--a report of 27 cases].
Wu Z; Pan Y; Liu J; Li L; Mo Y
Yan Ke Xue Bao; 1991 Jun; 7(2):98-102. PubMed ID: 1668881
[TBL] [Abstract][Full Text] [Related]
31. Clinical presentation and management of lacrimal gland tumours.
Wright JE; Stewart WB; Krohel GB
Br J Ophthalmol; 1979 Sep; 63(9):600-6. PubMed ID: 486378
[TBL] [Abstract][Full Text] [Related]
32. High-grade Mucoepidermoid Carcinoma of the Lacrimal Gland.
Hwang SJ; Kim KH
Korean J Ophthalmol; 2018 Oct; 32(5):426-427. PubMed ID: 30311467
[No Abstract] [Full Text] [Related]
33. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological investigation of secretory carcinoma cases including a successful treatment outcome using entrectinib for high-grade transformation: a case report.
Suzuki K; Harada H; Takeda M; Ohe C; Uemura Y; Kawahara A; Sawada S; Kanda A; Sengupta B; Iwai H
BMC Med Genomics; 2022 Jan; 15(1):6. PubMed ID: 34991563
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of mucoepidermoid carcinoma of the lacrimal duct.
Brar ST; Meyer D
Orbit; 2011 Jan; 30(1):34-6. PubMed ID: 21281078
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
Zhao M; Zhao DH; Cheng G; Yan YJ; Wang Z; He XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):533-538. PubMed ID: 30078266
[No Abstract] [Full Text] [Related]
38. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT
Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
[TBL] [Abstract][Full Text] [Related]
39. Sinonasal Secretory Carcinoma of Salivary Gland with High Grade Transformation: A Case Report of this Under-Recognized Diagnostic Entity with Prognostic and Therapeutic Implications.
Xu B; Aryeequaye R; Wang L; Katabi N
Head Neck Pathol; 2018 Jun; 12(2):274-278. PubMed ID: 28980201
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Approaches for Salivary Gland Tumors with Secretory and Microcystic Features.
Woo HY; Choi EC; Yoon SO
Head Neck Pathol; 2018 Jun; 12(2):237-243. PubMed ID: 29139086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
